Brian Atwood

-

Director Information, Funds, Firms

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Brian Atwood
Firm
Address201 Haskins Way, Suite 230
South San Francisco, CA 94080
Source
Associated Funds Form D Role 2011 - 2026 Raised AUM ($M)
CERO Therapeutics Holdings Inc 021-545301 Director
5.0 M
of 8.0 M
CERO Therapeutics Holdings Inc 021-525940 Director
1.2 M
of 1.2 M
CERO Therapeutics Holdings Inc 021-506000 Executive Officer
10.2 M
of 10.2 M
Atreca Inc 021-321684 Director
125.0 M
of 125.0 M
Atreca Inc 021-293433 Director
35.0 M
of 35.0 M
Cell Design Labs Inc 021-265295 Executive Officer
22.9 M
of 22.9 M
Cell Design Labs Inc 021-265322 Executive Officer
4.0 M
of 4.0 M
Phaserx Inc 021-264676 Director

of 0.4 M
Opgen Inc 021-264019 Director
7.2 M
of 10.4 M
Phaserx Inc 021-254009 Director
4.0 M
of 4.0 M
Atreca Inc 021-252456 Director

of 0.7 M
Atreca Inc 021-252455 Director
57.3 M
of 57.3 M
Opgen Inc 021-244329 Director
2.6 M
of 2.6 M
Opgen Inc 021-234523 Director
1.2 M
of 1.5 M
Veracyte Inc 021-225555 Director
12.8 M
of 12.8 M
Opgen Inc 021-221240 Director
1.1 M
of 1.5 M
Immune Design Corp 021-219014 Director
0.0 M
of 0.0 M
Immune Design Corp 021-218940 Director
0.0 M
of 0.0 M
Five Prime Therapeutics Inc 021-214271 Director
21.0 M
of 21.0 M
Opgen Inc 021-208924 Director
4.0 M
of 4.0 M
Phaserx Inc 021-208169 Director

of 1.5 M
Clovis Oncology Inc 021-207178 Director
192.0 M
Immune Design Corp 021-205531 Director
48.5 M
of 57.8 M
Phaserx Inc 021-203901 Director
1.4 M
of 1.4 M
Phaserx Inc 021-199468 Director
0.5 M
of 1.4 M
Phaserx Inc 021-188838 Director
1.5 M
of 3.0 M
Phaserx Inc 021-180834 Director
1.6 M
of 1.6 M
Five Prime Therapeutics Inc 021-177000 Director
10.0 M
of 10.0 M
Opgen Inc 021-174955 Director
6.1 M
of 17.0 M
Phaserx Inc 021-173428 Director
3.6 M
of 4.7 M
Groove Biopharma Corp 021-170387 Director
4.5 M
of 6.0 M
Opgen Inc 021-169854 Director
3.5 M
of 3.7 M
Trius Therapeutics Inc 021-160869 Director
30.2 M
of 44.3 M
Opgen Inc 021-148629 Director
11.9 M
of 15.7 M
Five Prime Therapeutics Inc 021-147844 Director 7.5 M
of 7.5 M
Immune Design Corp 021-145953 Director
34.0 M
of 34.0 M
Veracyte Inc 021-143695 Director 9.3 M
of 28.4 M
Mirina Corp 021-141242 Director 3.9 M
Opgen Inc 021-66404 Director 4.0 M
of 8.2 M
Trius Therapeutics Inc 021-87409 Director 19.2 M
of 30.0 M
Helicos Biosciences Corp 021-61335 Director 10.0 M
of 10.0 M
Phaserx Inc 021-115661 Director 1.2 M
of 1.2 M
Immune Design Corp 021-119253 Director
0.0 M
of 0.0 M
Versant Venture Management LLC
Versant Affiliates Fund I-A LP 021-175482 Director
5.2 M
of 5.2 M
0.0
Versant Affiliates Fund I-B LP 021-175440 Director
11.6 M
of 11.6 M
0.1
Versant Side Fund II LP 021-175486 Director
3.6 M
of 3.6 M
1.2
Versant Side Fund I LP 021-175439 Director
5.0 M
of 5.0 M
0.4
Terms | Privacy | Guide
tony@aum13f.com